To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

NCT01725126 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: GSK2890457
DRUG: Metformin
DRUG: Placebo
DRUG: Liraglutide

Sponsor

GlaxoSmithKline